Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support
You are here: Home > Products > Negative Pressure Technology Platform > V.A.C. Therapy > V.A.C. Therapy System Fact Sheet
Print

V.A.C. Therapy System Fact Sheet

Overview

KCI's proprietary V.A.C.® Therapy System has revolutionized the way in which caregivers treat the most serious, complex wounds. V.A.C. Therapy utilizes an open-cell polymer foam dressing that is conformed to the wound bed. When sealed and placed under negative (vacuum) pressure, the system creates a unique wound healing environment that has been shown to promote the wound healing process, reduce edema, prepare the wound bed for closure, promote the formation of granulation tissue and remove infectious materials.

V.A.C. Therapy System Illustration

History

In 1996, KCI introduced this innovative approach to the treatment of serious, complex wounds through the use of sub-atmospheric or negative pressure. Known today as “negative pressure wound therapy” (NPWT), KCI’s proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy System has revolutionized the advanced wound care market and remains the most clinically proven alternative for the treatment of complex, hard-to-heal wounds.

Product Portfolio

The InfoV.A.C.® System (on left) is a wound healing therapy system designed for patients in the acute care setting.  

The ActiV.A.C.® System (on right) is designed for ambulatory patients and is used primarily in the home care setting.

VAC duo

The ABThera (image below) Open Abdomen Negative Pressure Therapy System addresses patient quality of life through an easy-to-use system designed to assist surgeons in the management and treatment of “open abdomen” and to help achieve primary fascial closure.

Abthera

Research and Development (R&D)

KCI continues to invest in innovation with an ongoing commitment to research and development aimed at improving patient outcomes while reducing the overall cost of care. In 2008, KCI invested more than $76 million in its R&D efforts, which are led by approximately 240 clinical research and development professionals.

Clinical Distinction

V.A.C.® Therapy is recognized as a significant, clinically proven advancement in wound care that promotes active wound healing at the cellular level utilizing three vital V.A.C. Therapy components:

V.A.C. Therapy at a Glance

 Patients Served  6 million worldwide*
 Usage Growth Rate  486 percent by prescribing physicians
 Units Manufactured  42,000
 Key Relationships Globally 21,000 hospitals and skilled nursing facilities
11,000 home health agencies
 Caregivers Trained (Continuing Education)  Accredited training for caregivers in all care settings.
 Customer Support  1,000+ member clinical sales team
24x7x365 Customer and Patient Support
Over 690,000 customers self-served in 2008 utilizing KCI Express®

* As of December 2011

Clinical Study Support

KCI’s V.A.C. Therapy System enjoys an unprecedented body of clinical evidence that demonstrates clinical efficacy and cost-effectiveness, with:

Contact:

For more information, or if you would like to register for the KCI media list, please contact the KCI Corporate Communications Department.

Kinetic Concepts, Inc.
Maggie.McMahon
Wireless 210-838-3329
media@kci1.com

Updated: January 09, 2012

Print
Bookmark this page. del.icio.us